Guido Bold
Impact in
- Organic Chemistry top 2%
- Synthesis and biological activity
- Asymmetric Synthesis and Catalysis
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer
- Chemical Synthesis and Analysis
Papers in
-
- HIV/AIDS drug development and treatment 9
-
- Asymmetric Synthesis and Catalysis 5
- Synthesis and biological activity 5
- Co-authors
- Pascal Furet (12 shared papers)Peter M. Traxler (4 shared papers)Thomas Meyer (8 shared papers)Paul William Manley (7 shared papers)Giorgio Caravatti (6 shared papers)Elisabeth Buchdunger (3 shared papers)Jeanette Marjorie Wood (5 shared papers)Rudolf O. Duthaler (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (9 papers)Helvetica Chimica Acta (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)ChemMedChem (2 papers)Tetrahedron Letters (2 papers)
- Partner nations
- SwitzerlandUnited StatesJapan
In The Last Decade
Guido Bold
47 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 68
- Organic Chemistry 550
- Molecular Biology 648
- Computational Theory and Mathematics 129
- Oncology 173
- Hematology 95
Countries citing papers authored by Guido Bold
This map shows the geographic impact of Guido Bold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Bold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Bold more than expected).
Fields of papers citing papers by Guido Bold
This network shows the impact of papers produced by Guido Bold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Bold. The network helps show where Guido Bold may publish in the future.
Co-authors
The 25 scholars most cited alongside Guido Bold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. | 2000 | 740 |
| 2 | 2001 | 280 | |
| 3 | 1997 | 194 | |
| 4 | 2000 | 193 | |
| 5 | 1998 | 154 | |
| 6 | 2003 | 122 | |
| 7 | 2002 | 88 | |
| 8 | 1987 | 79 | |
| 9 | 2008 | 78 | |
| 10 | 1989 | 69 | |
| 11 | 1996 | 58 | |
| 12 | 2003 | 58 | |
| 13 | 2004 | 56 | |
| 14 | 2002 | 55 | |
| 15 | 1992 | 54 | |
| 16 | 2000 | 54 | |
| 17 | 2017 | 53 | |
| 18 | 1992 | 49 | |
| 19 | 2004 | 48 | |
| 20 | 1997 | 47 |
About Guido Bold
Guido Bold is a scholar working on Infectious Diseases, Organic Chemistry, Molecular Biology, Hematology and Cancer Research, having authored 47 papers that have together received 3.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (10 papers), HIV/AIDS drug development and treatment (9 papers), Asymmetric Synthesis and Catalysis (5 papers), Synthesis and biological activity (5 papers), Acute Myeloid Leukemia Research (3 papers), NF-κB Signaling Pathways (2 papers), Chemical Synthesis and Analysis (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Organic Chemistry (550 citations), Molecular Biology (648 citations), Computational Theory and Mathematics (129 citations), Oncology (173 citations) and Hematology (95 citations). Guido Bold has collaborated with scholars based in Switzerland, United States and Japan. Frequent co-authors include Pascal Furet, Peter M. Traxler, Thomas Meyer, Paul William Manley, Giorgio Caravatti, Elisabeth Buchdunger, Jeanette Marjorie Wood, Rudolf O. Duthaler, Terence O’Reilly and Martin Riediker. Their work appears in journals such as Journal of Medicinal Chemistry, Helvetica Chimica Acta, Bioorganic & Medicinal Chemistry Letters, ChemMedChem and Tetrahedron Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.